Remco Keijser

Mr. Remco Keijser

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JVJantine van Voorden
Jantine van Voorden
RKRemco Keijser
Remco Keijser
GVGeertruda J. M. Veenboer
Geertruda J. M. Veenboer
SCSolange A. Lopes Cardozo
Solange A. Lopes Cardozo
DDDina Diek
Dina Diek
GAGijs Afink
Gijs Afink
Early placenta development involves cytotrophoblast differentiation into extravillous trophoblast (EVT) and syncytiotrophoblast (STB). Defective trophoblast development and function may result in severe pregnancy complications, including fetal growth restriction and pre-eclampsia. The incidence of these complications is increased in pregnancies of fetuses affected by Rubinstein–Taybi syndrome, a developmental disorder predominantly caused by heterozygous mutations in CREB-binding protein ( CREBBP ) or E1A-binding protein p300 ( EP300 ). Although the acetyltransferases CREBBP and EP300 are paralogs with many overlapping functions, the increased incidence of pregnancy complications is specific for EP300 mutations. We hypothesized that these complications have their origin in early placentation and that EP300 is involved in that process. Therefore, we investigated the role of EP300 and CREBBP in trophoblast differentiation, using human trophoblast stem cells (TSCs) and trophoblast organoids. We found that pharmacological CREBBP/EP300 inhibition blocks differentiation of TSCs into both EVT and STB lineages, and results in an expansion of TSC-like cells under differentiation-inducing conditions. Specific targeting by RNA interference or CRISPR/Cas9-mediated mutagenesis demonstrated that knockdown of EP300 but not CREBBP, inhibits trophoblast differentiation, consistent with the complications seen in Rubinstein–Taybi syndrome pregnancies. By transcriptome sequencing, we identified transforming growth factor alpha (TGFA, encoding TGF-α) as being strongly upregulated upon EP300 knockdown. Moreover, supplementing differentiation medium with TGF-α, which is a ligand for the epidermal growth factor receptor (EGFR), likewise affected trophoblast differentiation and resulted in increased TSC-like cell proliferation. These findings suggest that EP300 facilitates trophoblast differentiation by interfering with at least EGFR signaling, pointing towards a crucial role for EP300 in early human placentation.

Verified
Journal Article
Open access
PDF file
JVJantine van Voorden
Jantine van Voorden
SBSouad Boussata
Souad Boussata
RKRemco Keijser
Remco Keijser
MVMarloes Vermij
Marloes Vermij
MWMuriel Wagner
Muriel Wagner
GAGijs Afink
Gijs Afink
Placentation disorders, including severe preeclampsia and fetal growth restriction, have their origins in early pregnancy, whereas symptoms typically present later on. To investigate the pathogenesis of these diseases, there is a need for a reliable in vitro model system of early placenta development with known pregnancy outcomes. Therefore, we optimized the generation of human induced trophoblast stem cells (iTSCs) from term umbilical cord, enabling non-invasive collection of patient-derived material immediately after birth. Using a direct reprogramming approach previously described for dermal fibroblasts, we investigated the effects of three supplements (A-485, BMP4, and EPZ-6438) to assess their potential to enhance iTSC induction. The generated iTSCs fulfilled the criteria for bona fide first-trimester trophoblasts and exhibited key functional capacities, including long-term self-renewal, differentiation into hormone-producing syncytiotrophoblasts and invasive extravillous trophoblasts, and the formation of organoids. Furthermore, transcriptomic analysis revealed high similarity between the generated iTSCs and trophoblast stem cells derived from first-trimester placental tissue. The supplements did not improve the generation of iTSCs. In conclusion, we successfully generated bona fide iTSCs from term umbilical cord using a direct reprogramming approach, providing a robust and clinically relevant model to study early placentation mechanisms in patient-derived trophoblasts.

20 June 2026 in iScience
Verified
Journal Article
Open access
JVJantine van Voorden
Jantine van Voorden
FLFangxu Lin
Fangxu Lin
SBSouad Boussata
Souad Boussata
RKRemco Keijser
Remco Keijser
LBLiana Barenbrug
Liana Barenbrug
GAGijs Afink
Gijs Afink
Proper placental development requires extravillous trophoblast (EVT) differentiation and invasion into the maternal decidua to remodel spiral arteries and support fetal growth. Disruptions in these processes contribute to preeclampsia and fetal growth restriction. These pregnancy complications are common in women with immune-mediated inflammatory diseases, which are characterized by elevated levels of pro-inflammatory cytokines such as interferon-α (IFN-α) and tumor necrosis factor-α (TNF-α). However, the direct effects of these cytokines on EVTs remain unclear. Using human trophoblast organoid models, we demonstrate that IFN-α and TNF-α impair EVT invasion while preserving differentiation capacity. High-resolution imaging of untreated organoid-decidua co-cultures revealed extensive trophoblast invasion into decidual stroma and arteries, but invasion was substantially reduced particularly upon IFN-α treatment. Transcriptome profiling identified changes in several invasion-related pathways after cytokine exposure. These findings suggest that elevated IFN-α and TNF-α can directly impair trophoblast invasive capacity, potentially contributing to suboptimal placental development in inflammatory disorders.

Verified
Journal Article
Open access
PDF file
FLFangxu Lin
Fangxu Lin
RKRemco Keijser
Remco Keijser
GAGijs Afink
Gijs Afink
Extravillous trophoblast (EVT) differentiation is essential for placental development and successful pregnancy, yet the molecular mechanisms regulating this process remain incompletely understood. CREB-binding protein (CREBBP) and E1A-binding protein p300 (EP300) are closely related lysine acetyltransferases that function as transcriptional co-activators. Previous studies reported that EP300 depletion impairs EVT differentiation whereas CREBBP depletion has little or no effect. We found that CREBBP mRNA expression was approximately one-third of EP300 expression in trophoblast stem cells (TSCs) and differentiated trophoblast lineages. To investigate whether differential CREBBP and EP300 expression explains this asymmetry in EVT differentiation initiation, we combined siRNA-mediated knockdown, CRISPR-generated CREBBP-deficient TSCs, pharmacological inhibition, and lentiviral Crebbp overexpression during EVT differentiation. While CREBBP depletion alone produced minimal phenotypic effects, CREBBP-deficient cells displayed increased sensitivity to the CREBBP/EP300 inhibitor A-485, with inhibitory effects appearing at lower A-485 concentrations in cells with reduced CREBBP level. Moreover, increased CREBBP expression partially rescued the EP300-depletion phenotype, including EVT-like morphology and selected differentiation marker expression. Together, these findings demonstrate that CREBBP contributes to EVT differentiation, but its role is obscured by its lower endogenous expression. We propose that the combined contributions of CREBBP and EP300, rather than EP300-specific activity alone, influence human trophoblast differentiation efficiency.

1 January 2015 in Pregnancy Hypertension
Verified
Journal Article
Closed access
JJJiska M. Jebbink
Jiska M. Jebbink
RBRolf Boot
Rolf Boot
RKRemco Keijser
Remco Keijser
PMPerry D Moerland
Perry D Moerland
JAJan Aten
Jan Aten
CRCarrie Ris-Stalpers
Carrie Ris-Stalpers

24 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
RBRobbert P. Berkhout
Robbert P. Berkhout
RKRemco Keijser
Remco Keijser
SRSjoerd Repping
Sjoerd Repping
CLCornelis B. Lambalk
Cornelis B. Lambalk
GAGijs Afink
Gijs Afink
GHGeert Hamer
Geert Hamer
Implantation failure is one of the major success limiting factors in human reproduction. Despite, the mechanisms that determine successful human embryo implantation remain largely unknown. We here show that high-quality human preimplantation embryos secrete soluble signaling factors, including micro RNA (miRNA) hsa-miR-320a, that promote migration of human endometrial stromal cells (hESCs). By using miRNA mimics and inhibitors, we demonstrate that hsa-miR-320a alone can stimulate migration of decidualized hESCs, accurately resembling the response typically triggered only by high-quality embryos. Transcriptome analysis further demonstrated that this effect is very likely mediated via altered expression of genes involved in cell adhesion and cytoskeleton organization. In conclusion, by secreting hsa-miR-320a, high-quality human preimplantation embryos directly influence endometrial stromal cells, most likely to prime the endometrium at the implantation site for successful implantation. Together, our results indicate that hsa-miR-320a may be a promising target to further increase success rates in assisted reproduction.